Fried Robert N
Director, Chief Executive Officer · 3 filings · Latest: Jun 30, 2026
Niagen Bioscience, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NAGE | Fried Robert N | Director, Chief Executive Officer | Apr 24, 2026 | Option Exercise | $2.61 | 20,000 | $52.2K | 1,058,981 |